Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography  by Ren, Jian-Fang et al.
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eft Atrial Thrombus Associated
ith Ablation for Atrial Fibrillation:
dentification With Intracardiac Echocardiography
ian-Fang Ren, MD, FACC, Francis E. Marchlinski, MD, FACC, David J. Callans, MD, FACC
hiladelphia, Pennsylvania
OBJECTIVES This study reports the incidence of, risk factors for, and management of left atrial (LA)
thrombus documented by intracardiac echocardiography (ICE) during LA ablation for atrial
fibrillation (AF).
BACKGROUND Thrombus formation is a risk associated with LA ablation procedures.
METHODS Intracardiac echocardiography imaging was performed in 232 patients (184 men, average age
55  11 years) with AF undergoing pulmonary vein ostial ablation.
RESULTS Anticoagulation (activated clotting time 250 s) was maintained after dual transseptal
catheterization. Left atrial thrombus (n  30) was observed in 24 of 232 patients (10.3%).
Thrombi measured 12.9  11.1 mm (length) and 2.2  1.3 mm (width) and were attached
to a sheath or mapping catheter. Most thrombi (27 of 30, 90%) were eliminated from the LA
by withdrawal of the sheath and catheter into the right atrium (RA). Two thrombi became
wedged in the interatrial septum and incompletely withdrawn into the RA, and one was
recognized only on post-procedure review of ICE images. Patients with LA thrombus had an
increased LA diameter (4.8  0.5 vs. 4.5  0.6 cm, p  0.02), spontaneous echo contrast
(67% vs. 3%, p  0.0001) and a history of persistent AF (29% vs. 6%, p  0.0002).
Multivariate discriminant analysis showed that spontaneous echo contrast (f  97.9, p 
0.0001) was the most important determinant of LA thrombus formation. No patient with LA
thrombus suffered a clinical thromboembolic complication.
CONCLUSIONS Left atrial thrombus identified on ICE may occur during LA catheter ablation procedures
despite aggressive anticoagulation. Spontaneous echo contrast may predict risk for LA
thrombus formation. Left atrial thrombus may be successfully withdrawn into the RA under
ICE imaging with no overt complications. (J Am Coll Cardiol 2004;43:1861–7) © 2004 by
the American College of Cardiology Foundationl
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cadiofrequency (RF) catheter ablation is an effective ther-
py for the treatment of many cardiac tachyarrhythmias.
ne of the major complications associated with RF ablation
s the risk of thromboembolism. The reported incidence of
hromboembolic complications during ablation procedures
s 0.6%, increasing to 1.8% to 2% during left heart proce-
ures (1). Limited data exist regarding the risk of more
omplicated left heart procedures such as ablation of atrial
brillation (AF) (2). Intracardiac echocardiography (ICE)
an detect and monitor left atrial (LA) thrombus (3). This
tudy is designed to report the incidence, associated risk
actors, and outcome of our initial experience managing LA
hrombus during catheter ablation.
ETHODS
atient characteristics. From September 2000 to Decem-
er 2002, 232 patients (184 men and 48 women; mean age
5  11 years, range 17 to 80) underwent isolation of at
From the Division of Cardiovascular Medicine, Department of Medicine, Univer-
ity of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania. Drs. Ren and
allans are faculty members of AcuNav peer training courses and have received
onorarium for the training courses.
Manuscript received July 25, 2003; revised manuscript received January 9, 2004,6ccepted January 12, 2004.east one pulmonary vein (PV) ostium for treatment of focal
aroxysmal (n  212) or persistent (n  20) AF refractory
o antiarrhythmic medications (Table 1). All patients gave
ritten informed consent. All procedures followed the
nstitutional guidelines of the University of Pennsylvania
ealth System. Cardiovascular disease was present in 91
atients (hypertension in 70, coronary artery disease in 16,
ild aortic stenosis in 4, and prior resection of a LA
yxoma in 1). All others had no structural heart disease
emonstrated by history, stress imaging, and transthoracic/
ransesophageal echocardiographic study. Patients were
outinely anticoagulated before the catheter ablation with
ong-term coumadin therapy. As a result, 90% of the
atients were taking coumadin before the ablation proce-
ure. All patients were admitted the day before the proce-
ure for continuous heparin administration to achieve a
artial thromboplastin time of 60 to 80 s. In addition, 325
g of aspirin was administered on the morning of the
lanned ablation procedure.
maging system and technique. All ablation procedures
ere guided by ICE. Intracardiac echocardiography imag-
ng was performed using a Sequoia diagnostic ultrasound
atheter (5.5 to 10 MHz, 10 F). The ICE tip contains a
4-element vector phased-array transducer scanning in the
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imensional and M-mode image and pulsed/continuous
oppler and color flow imaging with tissue penetration up
o a depth of 16 cm. During each procedure, the ICE
atheter was inserted into the femoral vein through an 11 F
ntroducer sheath and advanced into the right atrium (RA).
s previously described, ICE imaging was used to guide
ransseptal catheterization, assist positioning of the map-
ing and ablation catheters at the PV ostium, measure PV
stial flow before and after RF lesions, and monitor for
ossible complications (3,4). During ablation procedures,
hrombus formation in the LA was monitored continuously
nline with ICE imaging by a dedicated operator for all but
ne patient. If a thrombus was documented, the timing of
ts development and its size, location, and outcome were
oted.
For this study, spontaneous echo contrast, defined as
lowly swirling non-homogeneous amorphous echoes in the
A (Fig. 1), was specifically evaluated with ICE at 7.5
Hz and was distinguishable from background noise or
peckle by manipulation of gain settings before and during
he ablation procedure.
apping and ablation procedure. Our mapping and ab-
ation techniques have been previously described (4–6).
riefly, multipolar catheters were placed in the RA and in
he coronary sinus for recording and internal cardioversion.
ual transseptal catheterization with ICE imaging guid-
nce was performed to place two 8F Mullins sheaths and
Abbreviations and Acronyms
ACT  activated clotting time
AF  atrial fibrillation
ICE  intracardiac echocardiography
LA  left atrial/atrium
LVEF  left ventricular ejection fraction
PV  pulmonary vein
RA  right atrium
RF  radiofrequency
Table 1. Clinical, Echocardiographic, and Proc
LA Thrombus Formation
N
Thr
Age (yrs) 55
Gender (male/female) 16
Underlying heart disease (%) 39.9 (
Previous embolic event (%) 3.8 (
Persistent AF (%) 6.7 (
AF duration (yrs) 6.7
Unsuccessful drugs 3.7
LVEF (%) 56
LA diameter (cm) 4.5
LA diameter/LVEF(cm  100) 8.4
Spontaneous echo contrast (%) 3.4 (
Number of isolated PV/patient 3.1
Acute successful PV isolation (%) 98.6 (AF atrial fibrillation; LA left atrial; LVEF left ventricular ejosition through the sheaths a circular multipolar mapping
atheter (Lasso) and an ablation catheter (Navistar, Bio-
ense Webster, Diamond Bar, California) within the LA.
ulmonary vein isolation was achieved by applying RF
nergy to the LA/PV junction (4). Radiofrequency energy
up to 40 W, 52°C, and 90 s) was deployed at each targeted
V ostium and the surrounding LA wall until electrical
solation of PV from LA was achieved. All patients were
nticoagulated with heparin after initial catheter placement.
bolus of 5,000 to 8,000 U of heparin was routinely
dministered immediately after transseptal puncture, fol-
owed by a continuous infusion of 1,000 to 1,500 U/h.
eparin dosing was guided based on weight, with 5,000 to
,000 U followed by 1,000 to 1,200 U/h infusion for weight
100 kg and 7,000 to 8,000 U followed by 1,300 to 1,500
/h for weight 100 kg. Activated clotting times (ACT)
etween 250 and 300 s were confirmed at 15 min after
nitial bolus and at 30-min intervals. An additional heparin
olus of 1,000 to 3,000 U was administered for any ACT
alues 250 s. All LA sheaths were continuously flushed
ith heparinized solution at 200 cc/h.
anagement of LA thrombus. After ICE recognition of
A thrombus the following management strategy was de-
loyed: 1) Anticoagulation status was confirmed, and addi-
ional heparin was administered as a bolus and continuous
nfusion to achieve an ACT 300 s. 2) The sheath and
atheter on which thrombus was identified were immediately
ithdrawn into the RA as a single unit under careful ICE
maging monitoring. 3) If complete withdrawal into the RA
as noted, the catheter and/or sheath were removed from the
ody under careful hemodynamic and oxygen saturation mon-
toring. 4) In all but the first patient the sheath and/or catheter
as replaced and readvanced into the RA, and catheters
without sheath support) were re-advanced into the LA using
ppropriate catheter exchange and manipulation techniques to
ontinue the procedure. 5) A decision to abort the ablation
rocedure and not recross into the LA was left to the
lectrophysiologist but was typically based on failure to remove
al Variables in Patients With and Without
s
LA
Thrombus p
52  11 NS
19/5 NS
8) 33.3 (8/24) NS
) 0
5) 29.2 (7/24)  0.0002
0 6.9  3.3 NS
9 3.5  1.8 NS
51  11 NS
6 4.8  0.5  0.02
7 9.8  3.0 NS
) 66.7 (16/24)  0.0001
1 3.4  1.0 NS
08) 87.5 (21/24)  0.002edur
o LA
ombu
 11
5/43
83/20
8/208
13/19
 6.
 1.
 10
 0.
 2.
7/208
 1.
205/2ection fraction; NS not significant; PV pulmonary vein.
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fter continuing the procedure.
tatistical analysis. Measurements are expressed as mean
SD. Statistically significant differences for clinical, echo-
ardiographic, and procedural variables between the LA
hrombus and non-thrombus formation patient groups were
etermined using unpaired t test or chi-square test as
ppropriate. To further identify predictors of LA thrombus
ormation, all variables were subjected to a multivariate
tepwise discriminant analysis (NCSS 2001) in which inde-
endent variables were considered candidates for forward
ntry into the function if their association with LA throm-
us formation and their contribution to the selection func-
ion were significant (p  0.15). A p value of 0.05 was
onsidered statistically significant.
ESULTS
ncidence, timing, and characteristics of LA thrombus
ormation. Left atrial thrombus (n  30) was observed
ith ICE imaging in 24 of 232 patients (10.3%). Repeat
hrombus formation (i.e., recurrence after sheath/catheter
emoval from body and reinsertion of catheter into the LA)
as observed once in four patients and twice in one patient
espite maintaining ACT to 300 s. Left atrial thrombi
ccurred before RF energy application in 12 of the 24
atients (50%) and were noted 35  24 (range 6 to 87) min
fter transseptal catheterization in that group. In the re-
aining 12 patients, LA thrombi occurred after starting RF
nergy application at 166  60 (range 92 to 299) min after
ransseptal catheterization and 79  56 (range 1 to 168)
in after starting RF energy application.
Thrombus formation in both groups was not associated
ith RF energy delivery. The thrombi were characteristi-
ally single, linear, and mobile. Thrombi were attached to a
igure 1. Intracardiac echocardiography images with the transducer (7.5 M
s slowly swirling amorphous echoes in a dilated (diameter 5.2 cm) left at
rominent during sheath flushing with heparinized solution (right panel)heath in 17 patients or Lasso catheter in 13 patients and tere never noted to be attached to the ablation catheter
Fig. 2). Left atrial thrombi attached to the sheath were at
he distal end of the sheath in 13 patients and at 20  16 (3
o 38) mm proximal to the end of sheath in four patients;
hrombi attached to the Lasso catheter were at the distal end
f the shaft in five patients and at 16  10 (5 to 35) mm
roximal to the end of the shaft in eight patients. No mural
r mobile thrombus attached to any RF lesion was observed
nder ICE imaging monitoring. The thrombi measured
2.9 11.1 mm (range 3 to 40 mm) in maximal length and
.2  1.3 mm (range 0.5 to 5.8 mm) in maximal width.
anagement of LA thrombus formation. Twenty-seven
f the 30 thrombi (90%) were immediately eliminated from
he LA by withdrawal of the sheath and catheter because
hey were firmly attached to the sheath or catheter. Intra-
ardiac echocardiography imaging confirmed withdrawal
nto the RA (Fig. 2). Two thrombi were wedged into the
nteratrial septum with a small residual end in the LA as a
esult of attempted withdrawal into the RA. Reassessment
ith ICE at 24 h after maintaining ACT 300 s docu-
ented resolution of one thrombus and marked reduction
n size of another (Fig. 3). The remaining thrombus
ccurred during the single procedure without a primary
cho operator and was not detected until a retrospective
eview of recorded images after procedure. Documentation
f removal to the RA was not confirmed in this patient. Of
ote, although thrombi were identified to be withdrawn
ompletely from the LA into the RA in most patients,
hrombi were recovered outside the body in only 8 of 30
atients. The gross appearance of the thrombotic material
as as a strand of gelatinous material, which was not the
haracteristic char related to RF energy application. In the
emaining thrombi we assumed that the thrombi had
islodged in the venous system during withdrawal. Impor-
placed in the right atrium (RA) demonstrate spontaneous echo contrast,
(LA) (left panel). Slowly swirling non-homogeneous echoes become moreHz)
riumantly, none of the patients developed any respiratory
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odynamic status with the withdrawal of the catheters and
heaths.
The ablation procedure was terminated before isolation of
ll targeted PVs in three patients because of the thrombus
edging into the intraatrial septum (2 patients) and recur-
ent thrombus upon reinsertion of the catheters into the LA
espite increase in ACT to 300 s (1 patient). In the
emaining 21 patients mapping and ablation catheters were
epositioned in the LA for completion of the ablation
rocedure. Additional thrombus formation was noted in
our additional patients while we maintained an ACT300
as described, but completion of the ablation procedure had
een achieved and thrombus was again safely withdrawn
nto the RA. During the entire procedure all patients had
igure 2. Intracardiac echocardiography images with transducer placed in the
.9  4.2 mm) attached at the sheath of lasso (left upper panel), pulling the
rom the left atrium (LA) (left lower panel) into the RA (right lower panelemodynamic and continuous oxygen saturation monitor- sng besides the neurologic monitoring. The patients under-
ent neurologic examinations immediately after and then
aily after the catheter ablation during the remainder of the
haracteristic three- to four-day hospitalization. All patients
nderwent a repeat evaluation during the four- to six-week
ollow-up visits. None of the patients in the study cohort
ith LA thrombus had any neurologic complaints, and the
etailed neurologic examinations were always normal, indi-
ating that no patient experienced a clinical intra/post-
rocedural thromboembolic complication (up to 10-month
ollow-up). No further diagnostic study, such as head CT or
/Q scan, was performed in the study cohort.
actors predicting LA thrombus formation. Patient char-
cteristics, ablation characteristics, and acute procedure out-
ome are listed in Table 1. Univariate analysis demon-
atrium (RA) demonstrate a single, linear, and mobile thrombus (arrow, size
/lasso with thrombus back (right upper panel) and withdrawal of thrombus
 aorta; LV  left ventricle. Other abbreviations as in Figure 1.right
sheath
). Aotrated that patients with LA thrombus formation had
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May 19, 2004:1861–7 Left Atrial Thrombus in Ablation of AFncreased LA diameter (4.8  0.5 vs. 4.5  0.6 cm, p 
.02), more prevalent spontaneous echo contrast (16 of
4 [67%] vs. 7 of 208 [3%], p  0.0001) and persistent
F (7 of 24 [29%] vs. 13 of 208 [6%], p  0.0002)
ompared to patients without thrombus formation. In-
erestingly, a history of previous thromboembolic events
8 patients) was noted only in patients without LA
hrombus formation (Table 1). To further identify pre-
ictors of LA thrombus formation, 12 clinical, echocar-
iographic, and procedural variables listed in Table 1
ere subjected to a stepwise multivariate discriminant
nalysis. Stepwise forward selection analysis of the vari-
bles showed that spontaneous echo contrast in LA (f 
7.9, p  0.0001) was the most important determinant of
A thrombus formation. Nearly 70% (16 of 23) patients
ith evidence of spontaneous echo contrast developed an
A thrombus during the ablation procedure. Gender,
ge, underlying heart disease, history of embolic event,
ersistent AF, duration of AF, unsuccessful drugs (f 
.55, p  0.07), number of isolated PVs, LA diameter (f
1.12, p  0.3), and left ventricular ejection fraction
LVEF) (f  2.98, p  0.091) and their index (LA
iameter/LVEF) (f  1.65, p  0.21) did not indepen-
ently predict LA thrombus formation.
The ACT measurements in this study cohort indicated
hat there was no statistical difference for initial ACT values
fter the initial bolus of heparin between patients with LA
hrombus (278 27 s, range 222 to 316 s) and no thrombus
ormation (272  29 s, range 202 to 319 s). In this study
opulation, 99% of patients had ACT values documented to
e 250 s within 30 min after the initial bolus of heparin.
ny ACT values 250 s resulted in the immediate admin-
stration of heparin bolus (1,000 to 3,000 U) with subse-
uent ACT value 250 s confirmed within 15 min. Left
trial thrombus formation was not seen during such a
igure 3. Intracardiac echocardiography images demonstrate LA thrombus
n size (2.8  2.0 mm2) under anticoagulation with follow-up images afteransient value of ACT 250 s. No patient in this studyohort was noted to have ACT values consistently 300 s
uring the entire procedure.
ISCUSSION
he current report documents the ability of a phased-array
ltrasound catheter to monitor in real time and detect
hrombus formation in the LA during catheter ablation
rocedures for AF. Our study documents an unexpected
igher incidence of ICE-documented LA thrombus forma-
ion of 10.3% during LA ablation related to presence of
heaths/catheters in a consecutive series of 232 patients with
F. The thrombus: 1) appears to commonly attach to the
ransseptal sheath and/or the circular mapping catheter
Lasso) despite anticoagulation with heparin to ACT 250
; 2) appears to be firmly attached to sheath and/or catheter
nd can be typically withdrawn as a unit into the RA with
low risk of embolic events; and 3) appears most likely to
evelop in patients who demonstrate the presence of spon-
aneous echo contrast.
A thrombus formation during AF ablation procedures.
he reported incidence of systemic thromboembolic com-
lications associated with RF catheter ablation in the left
eart unrelated to AF has been reported to be as high as 2%
7). The risk of embolic stroke has been reported to be even
igher, maybe as high as 5%, in targeting the triggers for AF
ith ablation (2). Thrombus formation may be due to
ctivation of the coagulation cascade related to the place-
ent of intravascular catheters and the duration of the
blation procedure (8). Another possibility is that thrombus
s created by occasional tissue overheating, with energy
pplication and coagulum formation acting as the nidus for
ore complex thrombus formation. The present study sheds
ight on the possible pathophysiology related to clot forma-
ion in the LA during the AF ablation procedure.
4.0  3.9 mm2) wedged in the interatrial septum (left panel) and reduced
h (right panel). Abbreviations as in Figure 1.(sizeLeft atrial thrombus formation occurred after transseptal
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Left Atrial Thrombus in Ablation of AF May 19, 2004:1861–7atheterization but before RF applications in 50% of pa-
ients. In the remaining patients, although thrombus for-
ation was noted after RF ablation began, the LA throm-
us firmly attached at a sheath or mapping catheter and not
irectly to the ablation catheter or to the PV ostia at the site
f the ablation lesions. Furthermore, when the thrombus
as found attached to the Lasso mapping catheter, the
hrombus was always noted at the distal shaft, but not
irectly at the mapping electrodes. These observations
uggest that the observed LA thrombus formation is not
elated to RF energy application. The common finding of
hrombus formation only on the sheaths and/or circular
apping catheter shaft and not the ablation catheter was
ost likely due to their stable positioning for extended
eriods. In contrast, the ablation catheter tends to be
ontinuously manipulated. Of note, a single ablation cath-
ter technique used in a large series of AF ablation (589
atients) had no reported stroke complications (9). Because
CE was not used in this study, the possibility of thrombus
ormation in the LA on ablation catheter that is withdrawn
nto the RA and unrecognized must be considered. Obvi-
usly, one cannot exclude the possibility that thrombus
ormation may be due to intrinsic physical or component
haracteristics of the sheaths and circular mapping catheter.
mportantly, all sheaths were managed with continuous
nfusion of heparinized saline at rates of 200 cc/h, so
hrombus formation originating from stagnant flow sur-
ounding the catheter was unlikely. This study provides a
timulus for the development of novel materials and anti-
oagulant coating on intravascular catheters and sheaths to
revent thrombus formation. In addition, different anti-
hrombotic agents may influence the development of the
hrombi, and more investigation is required in this area.
Of note, the time for the development of thrombus varied
ramatically from 6 to 299 min after original transseptal
heath and catheter placement. No lapses in the mainte-
ance of adequate heparinization were observed as a possi-
le precipitant for thrombus formation, and thus a persis-
ent risk throughout the procedure must be assumed. These
ata support the use of vigilant continuous online ICE
onitoring to identify thrombus throughout the procedure.
n contrast to mechanical radial imaging catheter with fixed
ltrasonic frequency (10), the phased-array ultrasound cath-
ter has a changeable ultrasonic frequency from 5.5 to 10
Hz, which provides detailed LA images with adequate
maging depth, even in patients with dilated LA.
anagement of thrombus. Because the thrombus ap-
eared to be firmly attached to the catheter/sheath in the
A during observation with ICE imaging monitoring, we
ttempted withdrawal of the thrombus-attached catheter/
heath from the LA to prevent any serious systemic embolic
onsequences. We were successful in doing so in all cases in
hich the thrombus was detected during the online moni-
oring. In two patients, however, the thrombus became
edged in the interatrial septal puncture site and did notemain attached to the catheter/sheath withdrawn into the TA. We maintained aggressive anticoagulation and docu-
ented the diminution and/or absence of thrombus after
4 h and no evidence of clinical embolic phenomenon. We
elieve that immediate withdrawal of the thrombus remains
he best strategy because of the risk of thrombus dislodge-
ent with persistent catheter manipulation required for
uccessful PV isolation.
Of note, in most patients we could reinsert the catheters
nto the LA while maintaining an even higher ACT (300
) without additional thrombus formation. However, in five
atients recurrent thrombus formation was noted; one of
hem had repeated thrombus formation identified on two
eparate attempts. It is interesting to speculate on whether
aintaining an ACT 300 s or higher throughout the
rocedure may reduce the risk. The observed recurrences
ould suggest that the risk may not be definitely eliminated
fter a first thrombus, even with this greater degree of
nticoagulation, and that vigilant monitoring with ICE may
emain paramount.
pontaneous echo contrast as risk predictor for LA
hrombus formation. We document that spontaneous
cho contrast in the LA is easily detected with ICE
maging. The opacification of the blood with spontaneous
ontrast effect usually appears as a swirling, “smoke-like”
loud (11). This phenomenon has been recognized for many
ears and occurs primarily with evidence of stagnant blood,
specially with a large adynamic cardiac chamber. The
echanism for spontaneous echo contrast has not been fully
lucidated but may include erythrocyte rouleaux formation
nd/or interaction of erythrocytes and fibrinogen modulated
y shear forces (flow rate) (12–14). Some evidence suggests
hat LA spontaneous echo contrast may be a prothrombotic
ondition and a precursor to the development of a solid
hrombus (7,15). Our results support a possible causal
elationship. Given the high incidence of LA thrombus
ormation in 16 of 23 patients (70%) with spontaneous echo
ontrast during the ablation procedure, if ablation is ex-
anded to chronic AF, spontaneous echo contrast will be
ven more common and thrombi may become common.
ntracardiac echocardiography will assume more importance
n this regard.
tudy limitations. The number of study patients with LA
hrombus formation during the AF ablation procedure was
elatively small, and hence, the results with respect to the
ossibility of an embolic event during thrombus removal
nto the RA and predictors of thrombus formation should
e interpreted with caution. Because no further diagnostic
tudies were performed, subclinical embolic events cannot
e excluded, as fewer than a third of LA thrombi were
hysically removed from the patients. Clearly, there is a
eed for the development of strategies that might prevent
he development of the thrombus so that treatment is not
equired. Increased intensity of anticoagulation (ACT
300 to 370 s) may reduce LA thrombus formation,
specially in patients with spontaneous echo contrast (16).
he small sample size may explain the lack of association
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ormation. Moreover, patients with preexisting LA throm-
us were excluded before the ablation procedure. In addi-
ion, we did not measure serum levels of fibrinogen or other
lasma proteins to correlate with spontaneous echo contrast
nd thrombus formation during the ablation procedure.
uture studies addressing this issue would be of interest.
onclusions and clinical implications. Left atrial throm-
us formation is seen in 10% of LA catheter ablation
rocedures for AF involving the use of long intravascular
heaths, multiple mapping, and ablation catheters. These
hrombi can occur despite anticoagulation to ACT 250 s
nd careful sheath management with continuous heparin-
zed solution infusion. Thrombi develop most commonly on
heaths and mapping (Lasso), but not ablation catheters.
pontaneous echo contrast in LA may predict LA thrombus
ormation. Left atrial thrombi may be successfully with-
rawn into the RA under ICE imaging monitoring with no
vert complications. These data are important in view of the
ncrease in left heart interventional electrophysiologic pro-
edures requiring multiple transseptal long sheath/catheter
lacement and the known risk of thromboembolic compli-
ations. The suggested management strategy with continu-
us ICE imaging monitoring may prevent or decrease LA
hrombus complications.
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